Vasoconstriction produced in the iris-ciliary body of the cat eye by stimulation of local ganglion-like receptors.
D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002924:Ciliary Body / Q000098:blood supply*; D003250:Constriction; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000502:physiology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007498:Iris / Q000098:blood supply*; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010862:Pilocarpine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000502:physiology*; D014043:Tolazoline / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014666:Vasomotor System / Q000502:physiology*
D000317:Adrenergic alpha-Antagonists; D006584:Hexamethonium Compounds; D010879:Piperazines; D014662:Vasoconstrictor Agents; D010862:Pilocarpine; D010643:Phenoxybenzamine; D001285:Atropine; D010830:Physostigmine; D014043:Tolazoline; D000109:Acetylcholine; D009638:Norepinephrine